A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol

Peer Review reports

Original Submission
19 Nov 2019	Submitted	Original manuscript
17 Dec 2019	Author responded	Author comments - Nicholas Brown
5 Feb 2020	Author responded	Author comments - Nicholas Brown
Resubmission - Version 2
17 Dec 2019	Submitted	Manuscript version 2
Publishing
11 Feb 2020	Editorially accepted
12 Mar 2020	Article published	10.1186/s12885-020-6624-y

Back to article page